Skip to main content
Thorax logoLink to Thorax
. 1979 Feb;34(1):57–62. doi: 10.1136/thx.34.1.57

Value of measuring serum angiotensin I converting enzyme and serum lysozyme in the management of sarcoidosis.

C W Turton, E Grundy, G Firth, D Mitchell, B G Rigden, M Turner-Warwick
PMCID: PMC471008  PMID: 220748

Abstract

Serum angiotensin I converting enzyme (ACE) and lysozyme have been measured in 23 controls, 115 patients with sarcoidosis, and 64 with other chest diseases. Both enzymes were significantly raised in sarcoidosis. ACE was raised above the normal range in 21 of 72 (29%) patients with definite sarcoidosis and in 17 of 38 (45%) of those who were untreated and seen within one year of presentation. The rise discriminated usefully between those with stable and progressive disease (5% and 62% respectively). Lysozyme was raised in 50 of 72 (69%) patients with sarcoidosis but also in 11 of 54 (20%) patients with other chest diseases. Discrimination between stable and progressive disease was useful only if very high levels were considered. Five patients had serial measurements after treatment with oral steroids and showed a progressive fall in levals of both enzymes, but patients with other diseases also showed a significant fall within the normal range when so treated. Measurement of these enzymes may help in the management of some cases of sarcoidosis, but results require critical interpretation.

Full text

PDF
57

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashutosh K., Keighley J. F. Diagnostic value of serum angiotensin converting enzyme activity in lung diseases. Thorax. 1976 Oct;31(5):552–557. doi: 10.1136/thx.31.5.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fanburg B. L., Schoenberger M. D., Bachus B., Snider G. L. Elevated serum angiotensin I converting enzyme in sarcoidosis. Am Rev Respir Dis. 1976 Sep;114(3):525–528. doi: 10.1164/arrd.1976.114.3.525. [DOI] [PubMed] [Google Scholar]
  3. LITWACK G. Photometric determination of lysozyme activity. Proc Soc Exp Biol Med. 1955 Jul;89(3):401–403. doi: 10.3181/00379727-89-21824. [DOI] [PubMed] [Google Scholar]
  4. Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 1975 Sep;59(3):365–372. doi: 10.1016/0002-9343(75)90395-2. [DOI] [PubMed] [Google Scholar]
  5. Lieberman J. The specificity and nature of serum-angiotensin-converting enzyme (serum ACE) elevations in sarcoidosis. Ann N Y Acad Sci. 1976;278:488–497. doi: 10.1111/j.1749-6632.1976.tb47061.x. [DOI] [PubMed] [Google Scholar]
  6. Pascual R. S., Gee J. B., Finch S. C. Usefulness of serum lysozyme measurement in diagnosis and evaluation of sarcoidosis. N Engl J Med. 1973 Nov 15;289(20):1074–1076. doi: 10.1056/NEJM197311152892007. [DOI] [PubMed] [Google Scholar]
  7. Selroos O., Klockars M. Serum lysozyme in sarcoidosis. Evaluation of its usefulness in determination of disease activity. Scand J Respir Dis. 1977 Apr;58(2):110–116. [PubMed] [Google Scholar]
  8. Silverstein E., Friedland J., Ackerman T. Elevation of granulomatous lymph-node and serum lysozyme in sarcoidosis and correlation with angiotensin-converting enzyme. Am J Clin Pathol. 1977 Aug;68(2):219–224. doi: 10.1093/ajcp/68.2.219. [DOI] [PubMed] [Google Scholar]
  9. Silverstein E., Friedland J., Lyons H. A., Gourin A. Elevation of angiotensin-converting enzyme in granulomatous lymph nodes and serum in sarcoidosis: clinical and possible pathogenic significance. Ann N Y Acad Sci. 1976;278:498–513. doi: 10.1111/j.1749-6632.1976.tb47062.x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES